Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer

Clinical trial NCT00578071 · COMPLETED

Trial details

NCT number: NCT00578071
Sponsor: Brian Czito
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer of the Esophagus

Start date: 2007-12-01
Primary completion: 2011-07-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.